Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Treatment

From: Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy

  n %
Surgery N = 42   
Hysterectomy and bilateral salpingo-oophorectomy 42 100%
Lymphadenectomy   
 Pelvic 15 35.7%
 Pelvic and paraaortic 17 40.5%
 None 10 23.8%
Adjuvant chomotherapy N = 42   
Carboplatin/paclitaxel 7 16.7%
None 35 83.3%
Adjuvant radiotherapy N = 42   
Intravaginal HDR brachytherapy alone 5 11.9%
Intravaginal HDR brachytherapy and external beam radiotherapy 37 88.1%